PMC:7408073 / 84876-85186
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T476 | 67-75 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
2965 | 58-61 | Gene | denotes | ACE | Gene:59272 |
2966 | 62-66 | Gene | denotes | ACE2 | Gene:59272 |
2967 | 106-109 | Gene | denotes | ACE | Gene:59272 |
2968 | 114-118 | Gene | denotes | ACE2 | Gene:59272 |
2969 | 156-163 | Gene | denotes | Ang 1–9 | Gene:284 |
2970 | 187-195 | Gene | denotes | Ang (1–5 | Gene:284 |
2971 | 248-258 | Gene | denotes | bradykinin | Gene:3827 |
2972 | 209-219 | Gene | denotes | bradykinin | Gene:3827 |
2973 | 173-181 | Gene | denotes | Ang (1–7 | Gene:27329 |
2974 | 165-171 | Gene | denotes | Ang II | Gene:24179 |
2975 | 198-205 | Chemical | denotes | des-Arg |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1018 | 80-90 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T347 | 67-75 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
T5939 | 169-171 | Chemical | denotes | II | http://purl.obolibrary.org/obo/CHEBI_74067 |
T50578 | 202-205 | Chemical | denotes | Arg | http://purl.obolibrary.org/obo/CHEBI_16467|http://purl.obolibrary.org/obo/CHEBI_29952 |
T10557 | 209-219 | Chemical | denotes | bradykinin | http://purl.obolibrary.org/obo/CHEBI_3165 |
T93575 | 237-247 | Chemical | denotes | metabolite | http://purl.obolibrary.org/obo/CHEBI_25212 |
T353 | 248-258 | Chemical | denotes | bradykinin | http://purl.obolibrary.org/obo/CHEBI_3165 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T415 | 0-310 | Sentence | denotes | Unfortunately, complete analysis of circulating levels of ACE/ACE2 proteins and activities, together with ACE and ACE2 substrates and products i.e., Ang I, Ang 1–9, Ang II, Ang (1–7) and Ang (1–5), des-Arg(9)-bradykinin and the inactive metabolite bradykinin (1–7) is lacking to address the current hypothesis. |